MERCK & CO, INC. for MERCK & CO INC
What was lobbied
8 issue areas, each in the filer's own words, with who lobbied on it and where.
Manufacturing MAN
Drug Quality and Security Act (HR 3204)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT FILIPPONE New | — |
| ELI JOSEPH | — |
| JEROME MURRAY | — |
| KATIE OPPENHEIM | — |
| ANGELA M STEWART | — |
| JASON BENJAMIN VAN PELT | — |
Copyright/Patent/Trademark CPT
Patent reform (H.R. 3309)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELI JOSEPH | — |
| JEROME MURRAY | — |
| KATIE OPPENHEIM | — |
| ANGELA M STEWART | — |
| JASON BENJAMIN VAN PELT | — |
Health Issues HCR
Alzheimer's education (no specific bill); 340b (no specific bill); maternal health education (no specific bill); National Diabetes Clinical Care Commission Act (H.R. 1074); Hepatitis C education (no specific bill); adult vaccine policies (no specific bill); medication adherence (no specific bill)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT FILIPPONE New | Deputy CoS, Sen. Bob Graham |
| ELI JOSEPH | — |
| JEROME MURRAY | — |
| KATIE OPPENHEIM | — |
| ANGELA M STEWART | — |
| JASON BENJAMIN VAN PELT | — |
Taxation/Internal Revenue Code TAX
Comprehensive tax reform (no specific bill); transfer pricing of intangibles (no specific bill); territorial tax system (no specific bill); deferral of taxation of foreign earned income (no specific bill); tax base erosion (no specific bill).
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT FILIPPONE New | Deputy CoS, Sen. Bob Graham |
| ELI JOSEPH | — |
| JEROME MURRAY | — |
| KATIE OPPENHEIM | — |
| ANGELA M STEWART | — |
| JASON BENJAMIN VAN PELT | — |
Medicare/Medicaid MMM
Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Low Income Subsidy Copays in Part D (no specific bill); Independent Payment Advisory Board (S. 351, H.R. 351)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT FILIPPONE New | Deputy CoS, Sen. Bob Graham |
| ELI JOSEPH | — |
| JEROME MURRAY | — |
| KATIE OPPENHEIM | — |
| ANGELA M STEWART | — |
| JASON BENJAMIN VAN PELT | — |
Trade (domestic/foreign) TRD
Trans-Pacific Partnership (no specific bill); biologic data exclusivity (no specific bill); US-EU trade agreement (no specific bill); trade promotion authority (no specific bill); treatment of intellectual property in India (no specific bill); Playing Fair on Trade and Innovation Act (HR 3167); additives in beef cattle (no specific bill)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT FILIPPONE New | Deputy CoS, Sen. Bob Graham |
| ELI JOSEPH | — |
| JEROME MURRAY | — |
| KATIE OPPENHEIM | — |
| ANGELA M STEWART | — |
| JASON BENJAMIN VAN PELT | — |
Budget/Appropriations BUD
Deficit reduction (no specific bill); ADAP funding (no specific bill); Sequestration of FDA user fees (S. 1413, H.R.2775)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT FILIPPONE New | Deputy CoS, Sen. Bob Graham |
| ELI JOSEPH | — |
| JEROME MURRAY | — |
| KATIE OPPENHEIM | — |
| ANGELA M STEWART | — |
| JASON BENJAMIN VAN PELT | — |
Consumer Issues/Safety/Products CSP
Access to over-the-counter medications (no specific bill); compounding (no specific bill)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELI JOSEPH | — |
| JEROME MURRAY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.